Global pharmaceutical sales will slow in 2008, growing 5%-6% compared to 6%-7% in 2007, as the recent wave of patent expirations continues, according to an IMS Health forecast.
The FDA recommended that Takeda halt high-dose clinical studies of its TAK-475 cholesterol drug due to possible liver side effects, asking for additional data on the drug.
Auriga Laboratories, a specialty pharmaceutical company announced the launch of Coraz Lotion (hydrocortisone lotion USP, 2%) indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, such as Seborrheic Dermatitis.
GSW Worldwide, an inVentiv Health company, has been named agency of record by BioBehavioral Diagnostics Company for their McLean Motion and Attention Test, a non-invasive, diagnostic system that provides evidence-based measures of the core symptoms of attention deficit hyperactivity disorder.
To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.
All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam filter rules, please
use this domain name.
Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York
N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150 http://www.mmm-online.com/
You are subscribed as: %%EMAIL%%